Can hair loss be reversed? The answer depends on the type of alopecia, its underlying cause, and how promptly treatment is sought. Hair loss affects millions of people across the UK, ranging from temporary shedding triggered by stress or nutritional deficiency to permanent follicle damage caused by scarring conditions or genetic predisposition. Understanding the distinction between reversible and irreversible hair loss is essential before pursuing any treatment. This article outlines the main causes of hair loss, which types can be reversed, NHS-recognised treatments available in the UK, when loss may be permanent, and when to seek medical advice.

What Causes Hair Loss and Whether Reversal Is Possible

Reversal is possible in non-scarring alopecias where the follicle remains intact, but scarring alopecias permanently destroy follicles, making regrowth impossible in affected areas.

Hair loss — medically termed alopecia — is a common condition affecting both men and women across all age groups. Whether it can be reversed depends largely on its underlying cause, the type of hair loss involved, and how early treatment is sought. Understanding the root cause is therefore the essential first step before any treatment is considered.

Not sure if this is normal? Chat with one of our pharmacists →

Hair grows in cycles: a growth phase (anagen), a transitional phase (catagen), and a resting phase (telogen), after which the hair sheds and the cycle restarts. Disruption to this cycle — whether through hormonal changes, nutritional deficiencies, autoimmune activity, physical damage, or certain medications — can lead to thinning or shedding.

A clinically important distinction exists between non-scarring and scarring (cicatricial) alopecias. In non-scarring forms, the hair follicle remains intact and regrowth is often possible if the underlying cause is addressed. In scarring alopecias, chronic inflammation destroys the follicle and replaces it with scar tissue, making regrowth in affected areas impossible. Suspected scarring alopecia warrants prompt dermatological assessment to prevent further irreversible loss.

Key factors that influence whether hair loss can be reversed include:

• Duration of hair loss — the longer follicles remain inactive, the lower the likelihood of full recovery

• Follicle viability — if the follicle is scarred or destroyed, regrowth is unlikely

• Underlying cause — reversible triggers such as nutritional deficiency or stress carry a better prognosis than genetic or scarring conditions

• Age and hormonal status — these can influence follicle sensitivity and response to treatment

Important reversible causes include telogen effluvium (including postpartum shedding), nutritional deficiencies, hormonal disorders, drug-induced alopecia, alopecia areata, tinea capitis (scalp ringworm, particularly in children), anagen effluvium (for example, following chemotherapy), and trichotillomania (compulsive hair pulling). Each carries a different prognosis and requires a different management approach.

It is important to approach hair loss with realistic expectations. While many forms are treatable and some are fully reversible, others may only be managed rather than cured. A thorough clinical assessment is always recommended before beginning any treatment.

Types of Hair Loss That Can Be Reversed

Telogen effluvium, alopecia areata, anagen effluvium, tinea capitis, trichotillomania, and hair loss from nutritional deficiencies or hormonal disorders are all potentially reversible with timely treatment.

Several well-recognised types of hair loss are considered potentially reversible, particularly when identified and treated in a timely manner. Understanding which category applies to an individual is crucial in determining the most appropriate course of action.

Telogen effluvium is one of the most common reversible forms. It occurs when a significant physical or emotional stressor — such as surgery, severe illness, or prolonged psychological stress — pushes a large number of hair follicles into the resting phase simultaneously. Postpartum telogen effluvium, which occurs two to three months after childbirth, is a particularly common variant and typically resolves spontaneously within six to nine months. In most cases, once the triggering stressor is removed, the hair cycle normalises without specific treatment.

Anagen effluvium refers to sudden, diffuse hair loss during the active growth phase, most commonly caused by chemotherapy or radiotherapy. Hair typically regrows after treatment ends, though texture or colour may temporarily differ.

Alopecia areata is an autoimmune condition in which the immune system mistakenly attacks hair follicles, causing patchy hair loss. Because the follicles are not permanently destroyed, regrowth is possible — and in mild cases, hair may return without treatment. However, outcomes vary, and more extensive forms such as alopecia totalis (complete scalp hair loss) or alopecia universalis (total body hair loss) are less predictable.

Tinea capitis (scalp ringworm) is a fungal infection that causes patchy hair loss, scaling, and sometimes inflamed, boggy swellings (kerions). It is particularly common in children and requires systemic antifungal treatment. If diagnosed and treated promptly, hair regrowth is expected; however, delayed treatment — especially with a kerion — risks permanent scarring.

Trichotillomania is a condition characterised by recurrent, compulsive urges to pull out one's own hair. Hair loss is reversible if the behaviour stops, though the condition often requires psychological support, such as cognitive behavioural therapy (CBT).

Nutritional deficiency-related hair loss — most clearly linked to iron deficiency and low ferritin — is generally reversible once the deficiency is corrected. Evidence for the role of vitamin D, zinc, and B vitamins in hair loss is less consistent; supplementation should only be considered where a deficiency has been confirmed by blood tests, under medical guidance.

Hormonal hair loss, such as that associated with thyroid disorders or polycystic ovary syndrome (PCOS), can often be improved significantly once the underlying hormonal imbalance is treated.

Drug-induced alopecia may resolve after the causative medication is discontinued, though improvement is not always complete or rapid. Any changes to prescribed medicines should only be made after discussion with the prescribing clinician — patients should not stop or alter their medication without medical advice.

NHS-Recognised Treatments for Hair Regrowth

Topical minoxidil and oral finasteride (for men) are the main evidence-based options for pattern hair loss; baricitinib is NICE-approved for severe alopecia areata in specialist settings.

Several evidence-based treatments are available for hair loss in the UK. It is important to note that treatments for pattern hair loss (androgenetic alopecia) — including topical minoxidil and finasteride — are not routinely available on the NHS and are usually obtained via private prescription or purchased over the counter. Treatments for conditions such as alopecia areata are generally initiated and monitored in secondary care.

Minoxidil is the most widely used topical treatment for hair loss and is available without prescription in the UK (for example, as Regaine). Its precise mechanism is not fully understood, but it is thought to involve potassium channel opening and vasodilation, which may prolong the anagen (growth) phase. It is licensed for androgenetic alopecia in both men and women, with different licensed strengths and formulations for each. Use is generally recommended for adults aged 18 to 65 years, in line with the Summary of Product Characteristics (SmPC). Consistent, long-term use is required — results typically become visible after three to six months, and hair loss usually resumes if treatment is stopped.

Common side effects of minoxidil include scalp irritation and contact dermatitis. An initial increase in shedding may occur in the first few weeks of use and does not indicate treatment failure. Systemic absorption is low with topical use, but patients with cardiovascular conditions should seek medical advice before starting treatment. Minoxidil should not be used during pregnancy or breastfeeding.

Experiencing these side effects? Our pharmacists can help you navigate them →

Finasteride 1 mg is an oral prescription medication licensed in the UK specifically for male pattern hair loss in men. It works by inhibiting the enzyme 5-alpha reductase, thereby reducing levels of dihydrotestosterone (DHT), the hormone responsible for follicle miniaturisation in genetically susceptible individuals. Finasteride is not licensed for use in women and is contraindicated in pregnancy — women who are pregnant or may become pregnant should not handle crushed or broken tablets, as the active ingredient can be absorbed through the skin and may cause harm to a male foetus.

The MHRA has issued safety guidance highlighting that finasteride is associated with risks of sexual dysfunction (including decreased libido and erectile dysfunction), depression, and suicidal ideation. Patients should be made aware of these risks before starting treatment and should seek medical advice promptly if they experience any of these effects. As with minoxidil, hair loss typically resumes if finasteride is discontinued.

For alopecia areata, treatment options available in the UK include:

• Corticosteroid injections into affected areas to suppress local immune activity

• Topical corticosteroids for mild or patchy cases

• Immunotherapy with diphencyprone, used in specialist settings for more extensive disease

• Baricitinib (Olumiant), a JAK inhibitor approved by the MHRA and recommended by NICE (Technology Appraisal TA878) for severe alopecia areata in adults who meet specific eligibility criteria. It is initiated and monitored by specialists only. Important risks include serious infections, venous thromboembolism (VTE), and changes in blood counts requiring regular laboratory monitoring. It is contraindicated in pregnancy, and effective contraception is required during treatment and for a period after stopping. Patients should be counselled on these risks before starting.

Addressing confirmed nutritional deficiencies through GP-guided supplementation is also a recognised component of management where blood tests confirm a deficiency.

Patients who experience suspected side effects from any medicine for hair loss are encouraged to report these via the MHRA Yellow Card scheme (available at yellowcard.mhra.gov.uk).

When Hair Loss May Be Permanent

Androgenetic alopecia and scarring alopecias (e.g. lichen planopilaris, frontal fibrosing alopecia) are largely permanent; management focuses on slowing progression rather than achieving full regrowth.

Not all hair loss is reversible, and it is important to understand the conditions in which permanent loss is more likely. In these cases, the focus of management shifts from regrowth to slowing progression and exploring cosmetic or surgical options.

Androgenetic alopecia — commonly known as male or female pattern baldness — is the most prevalent form of hair loss and is largely driven by genetic predisposition and hormonal sensitivity. In men, this typically presents as a receding hairline and crown thinning; in women, it more commonly causes diffuse thinning over the top of the scalp. While treatments such as minoxidil and finasteride can slow progression and, in some cases, stimulate partial regrowth, they do not offer a permanent cure. Discontinuing treatment usually results in resumed hair loss.

Scarring alopecias (cicatricial alopecias) represent a group of conditions — including lichen planopilaris, frontal fibrosing alopecia, discoid lupus erythematosus, and central centrifugal cicatricial alopecia (which disproportionately affects people of African and Caribbean heritage and typically begins at the crown) — in which chronic inflammation destroys the hair follicle and replaces it with scar tissue. Once scarring has occurred, regrowth in the affected area is not possible. Early diagnosis and treatment are therefore critical to halt further progression, and prompt referral to a dermatologist is strongly advised if a scarring alopecia is suspected.

Traction alopecia, caused by prolonged tension on the hair from tight hairstyles, can become permanent if the follicle is repeatedly damaged over time. In its early stages, however, it is reversible if the causative styling practices are changed.

For individuals with permanent hair loss, hair transplant surgery (follicular unit transplantation or follicular unit extraction) may be considered in appropriate candidates. However, transplantation is not suitable in cases of active scarring alopecia or alopecia areata, and requires stable hair loss and adequate donor hair. These procedures are generally not available on the NHS and are performed privately. Scalp micropigmentation and high-quality hairpieces are also recognised non-surgical alternatives.

When to See a GP About Hair Loss

See a GP promptly if hair loss is sudden, patchy, accompanied by systemic symptoms, or associated with scalp changes — early investigation can identify reversible causes and prevent irreversible follicle damage.

Whilst hair loss is rarely a medical emergency, there are circumstances in which prompt assessment by a GP is strongly advisable. Early investigation can identify treatable underlying causes and prevent further, potentially irreversible, follicle damage.

You should consider contacting your GP if you notice:

• Sudden or rapid hair loss, particularly if occurring in patches or across the whole scalp

• Hair loss accompanied by other symptoms such as fatigue, unexplained weight changes, skin changes, or joint pain — which may suggest a systemic condition such as thyroid disease or lupus

• Scalp symptoms including redness, scaling, itching, pain, pustules, or loss of visible follicular openings — which may indicate a scarring alopecia or fungal infection requiring specific and prompt treatment

• Hair loss in a child, particularly with scalp scaling, broken hairs, 'black dots', or a boggy swelling (kerion) — these features suggest tinea capitis (scalp ringworm), which requires systemic antifungal treatment and, if a kerion is present, urgent assessment to prevent scarring

• Hair loss following a new medication — discuss this with your GP or prescribing clinician; do not stop or alter any prescribed medicine without medical advice

• Significant psychological distress related to hair loss, as this can have a meaningful impact on mental health and quality of life

At your appointment, your GP is likely to take a detailed medical and family history, examine the scalp, and arrange blood tests to investigate common reversible causes. In UK primary care, investigations typically include a full blood count (FBC), serum ferritin, and thyroid-stimulating hormone (TSH). Vitamin D, vitamin B12, and zinc levels are generally tested only where there is a specific clinical indication. If features of hyperandrogenism are present in women (for example, irregular periods, acne, or hirsutism), androgen levels (such as total testosterone and sex hormone-binding globulin) may also be checked. If a specialist cause is suspected — particularly a scarring alopecia — referral to a dermatologist will be arranged.

It is worth noting that many commercially marketed hair supplements are not supported by robust clinical evidence. Patients should be cautious of unregulated products making unsupported claims, and should always seek evidence-based advice from a qualified healthcare professional before beginning any treatment for hair loss.

Frequently Asked Questions